Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis.

Authors :: Rocca B
Fox KAA
Ajjan RA
Andreotti F
Baigent C
Collet JP
Grove EL
Halvorsen S
Huber K
Morais J
Patrono C
Rubboli A
Seljeflot I
Sibbing D
Siegbahn A
Ten Berg J
Vilahur G
Verheugt FWA
Wallentin L
Weiss TW
Wojta J
Storey RF
Source :: European heart journal [Eur Heart J] 2018 May 14; Vol. 39 (19), pp. 1672-1686f.
Publication Year :: 2018

Subjects :: Anticoagulants pharmacokinetics
Anticoagulants therapeutic use
Bariatric Surgery adverse effects
Cardiovascular Diseases complications
Fibrinolytic Agents adverse effects
Fibrinolytic Agents pharmacokinetics
Hemorrhage chemically induced
Humans
Nutrition Disorders etiology
Obesity complications
Obesity surgery
Platelet Aggregation Inhibitors pharmacokinetics
Platelet Aggregation Inhibitors therapeutic use
Postoperative Complications
Risk Factors
Body Mass Index
Fibrinolytic Agents therapeutic use
Thrombosis prevention & control

Full Text Access

Tools